
公共卫生PASC二甲双胍
二甲双胍和熊去氧胆酸未能改善新冠后恢复:随机对照试验的见解
By MedXY|2026年3月16日
一项随机临床试验表明,与安慰剂相比,二甲双胍或熊去氧胆酸(UDCA)均未显著改善SARS-CoV-2感染后急性期症状(PASC)的恢复,突显了寻找有效治疗长新冠的持续挑战。
Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.